5-HT1A receptor as a key player in the brain 5-HT system

Reviews in the Neurosciences

Volumn 24, Issue 2, 2013, Pages 191-204

  Popova, Nina K ^a   Naumenko, Vladimir S ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

5 HT system; 5 HT system autoregulation; 5 HT1A receptor; Depression and anxiety; Normal and pathological behavior; Receptor and gene functional interaction

Indexed keywords

AUTORECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SEROTONIN;

ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; AUTOREGULATION; DEFENSIVE BEHAVIOR; DEPRESSION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC REGULATION; HIBERNATION; HUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SUICIDE; ANIMAL; BEHAVIOR; BRAIN; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BEHAVIOR; BRAIN; GENE EXPRESSION REGULATION; HUMANS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN;

EID: 84877940035     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (151)

1. Ago, Y., Koyama, Y., Baba, A., and Matsuda, T. (2003). Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45, 1050-1056. (Pubitemid 37412250)
2. Albert, P.R. (2012). Transcriptional regulation of the 5-HT1A receptor: implications for mental illness. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2402-2415.
3. Albert, P.R. and Lemonde, S. (2004). 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10, 575-593. (Pubitemid 39546399)
4. Albert, P.R., Zhou, Q.Y., Van Tol, H.H., Bunzow, J.R., and Civelli, O. (1990). Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J. Biol. Chem. 265, 5825-5832.
5. Albert, P.R., Le Francois, B., and Millar, A.M. (2011). Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. Mol. Brain 4, 21.
6. Arango, V., Underwood, M.D., Boldrini, M., Tamir, H., Kassir, S.A., Hsiung, S., Chen, J.J., and Mann, J.J. (2001). Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25, 892-903. (Pubitemid 34031894)
7. Artigas, F., Romero, L., de Montigny, C., and Blier, P. (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19, 378-383. (Pubitemid 26270513)
8. Assie, M.B., Ravailhe, V., Faucillon, V., and Newman-Tancredi, A. (2005). Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. J. Pharmacol. Exp. Ther. 315, 265-272. (Pubitemid 41380520)
9. Azmitia, E.C. (2010). Evolution of serotonin: from sunlight to suicide. In: Handbook of the behavioral neurobiology of serotonin. C.P. Muller and B.L. Jacobs, eds. (London: Academic Press), pp. 3-22.
10. Bagchi, S. and Deshpande, S.B. (1999). Indian red scorpion (Buthus tamulus) venom-induced augmentation of cardiac reflexes is mediated through the involvement of peripheral 5-HT3 and central 5-HT1A receptor subtypes. Toxicon 37, 1697-1709. (Pubitemid 29397336)
11. Bantick, R.A., Deakin, J.F., and Grasby, P.M. (2001). The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J. Psychopharmacol. 15, 37-46. (Pubitemid 32242102)
12. Bantick, R.A., De Vries, M.H., and Grasby, P.M. (2005). The effect of a 5-HT1A receptor agonist on striatal dopamine release. Synapse 57, 67-75. (Pubitemid 40911521)
13. Bardin, L., Auclair, A., Kleven, M.S., Prinssen, E.P., Koek, W., Newman-Tancredi, A., and Depoortere, R. (2007). Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behav. Pharmacol. 18, 103-118. (Pubitemid 46398960)
14. Barnes, N.M. and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. (Pubitemid 29292403)
15. Benko, A., Lazary, J., Molnar, E., Gonda, X., Tothfalusi, L., Pap, D., Mirnics, Z., Kurimay, T., Chase, D., Juhasz, G., et al. (2010). Significant association between the C(-1019)G functional polymorphism of the HTR1A gene and impulsivity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 592-599.
16. Berg, K.A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., and Clarke, W.P. (1998). Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonistdirected trafficking of receptor stimulus. Mol. Pharmacol. 54, 94-104. (Pubitemid 28337591)
17. Blier, P. and de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226. (Pubitemid 24210726)
18. Blier, P. and Ward, N.M. (2003). Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry 53, 193-203. (Pubitemid 36135929)
19. Blier, P., Lista, A., and De Montigny, C. (1993). Differential properties of pre-and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J. Pharmacol. Exp. Ther. 265, 7-15. (Pubitemid 23320935)
20. Bortolozzi, A., Masana, M., Diaz-Mataix, L., Cortes, R., Scorza, M.C., Gingrich, J.A., Toth, M., and Artigas, F. (2010). Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. Int. J. Neuropsychopharmacol. 13, 1299-1314.
21. Bortolozzi, A., Castane, A., Semakova, J., Santana, N., Alvarado, G., Cortes, R., Ferres-Coy, A., Fernandez, G., Carmona, M.C., Toth, M., et al. (2012). Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol. Psychiatry 17, 612-623.
22. Bose, S.K., Mehta, M.A., Selvaraj, S., Howes, O.D., Hinz, R., Rabiner, E.A., Grasby, P.M., Turkheimer, F.E., and Murthy, V. (2011). Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain. Neuropsychopharmacology 36, 2258-2265.
23. Brandon, N.J. and Moss, S.J. (2000). Receptor cross talk: ligand-gated ion channels start to communicate. Sci. STKE 2000, pe1.
24. Carey, R.J., Depalma, G., Damianopoulos, E., Muller, C.P., and Huston, J.P. (2004). The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology (Berl.) 177, 46-54. (Pubitemid 40109913)
25. Carey, R.J., DePalma, G., Damianopoulos, E., Shanahan, A., Muller, C.P., and Huston, J.P. (2005). Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res. 1034, 162-171. (Pubitemid 40248528)
26. Carey, R.J., Shanahan, A., Damianopoulos, E.N., Muller, C.P., and Huston, J.P. (2008). Behavior selectively elicited by novel stimuli: modulation by the 5-HT1A agonist 8-OHDPAT and antagonist WAY-100635. Behav. Pharmacol. 19, 361-364.
27. Carrasco, G.A., Van de Kar, L.D., Jia, C., Xu, H., Chen, Z., Chadda, R., Garcia, F., Muma, N.A., and Battaglia, G. (2007). Single exposure to a serotonin 1A receptor agonist, (+) 8-hydroxy-2-(di-n -propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo . J. Pharmacol. Exp. Ther. 320, 1078-1086. (Pubitemid 46294064)
28. Celada, P., Puig, M., Amargos-Bosch, M., Adell, A., and Artigas, F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J. Psychiatry Neurosci. 29, 252-265. (Pubitemid 39185866)
29. Charest, A., Wainer, B.H., and Albert, P.R. (1993). Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line. J. Neurosci. 13, 5164-5171. (Pubitemid 24001002)
30. Cleare, A.J. and Bond, A.J. (2000). Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology (Berl.) 148, 344-349. (Pubitemid 30169750)
31. David, S.P., Murthy, N.V., Rabiner, E.A., Munafo, M.R., Johnstone, E.C., Jacob, R., Walton, R.T., and Grasby, P.M. (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25, 2586-2590. (Pubitemid 40365170)
32. de Boer, S.F., Lesourd, M., Mocaer, E., and Koolhaas, J.M. (1999). Selective antiaggressive effects of alnespirone in residentintruder test are mediated through 5-hydroxytryptamine1A receptors: a comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J. Pharmacol. Exp. Ther. 288, 1125-1133. (Pubitemid 29254150)
33. De Souza, R.J., Goodwin, G.M., Green, A.R., and Heal, D.J. (1986). Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists. Br. J. Pharmacol. 89, 377-384. (Pubitemid 16008692)
34. Del Tredici, A.L., Schiffer, H.H., Burstein, E.S., Lameh, J., Mohell, N., Hacksell, U., Brann, M.R., and Weiner, D.M. (2004). Pharmacology of polymorphic variants of the human 5-HT1A receptor. Biochem. Pharmacol. 67, 479-490. (Pubitemid 38232888)
35. Diaz-Mataix, L., Scorza, M.C., Bortolozzi, A., Toth, M., Celada, P., and Artigas, F. (2005). Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J. Neurosci. 25, 10831-10843. (Pubitemid 41692613)
36. Doherty, M.D. and Pickel, V.M. (2001). Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain. J. Comp. Neurol. 433, 390-400. (Pubitemid 32280659)
37. Dourish, C.T. (1987). Brain 5-HT1A receptors and anxiety. In: Brain 5-HT1A Receptors. Behavioral and neurochemical pharmacology. C.T. Dourish, S. Ahlenius and P.H. Hutson, eds. (London: Ellis Horwood), pp. 261-277.
38. Fargin, A., Raymond, J.R., Lohse, M.J., Kobilka, B.K., Caron, M.G., and Lefkowitz, R.J. (1988). The genomic clone G-21 which resembles a α-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335, 358-360.
39. Ferres-Coy, A., Santana, N., Castane, A., Cortes, R., Carmona, M.C., Toth, M., Montefeltro, A., Artigas, F., and Bortolozzi, A. (2013). Acute 5-HT(1A) autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology (Berl.) 255, 61-74.
40. Filip, M., Alenina, N., Bader, M., and Przegalinski, E. (2010). Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict. Biol. 15, 227-249.
41. Fregoneze, J.B., Ferreira, H., Soares, T., Luz, C.P., Bulcao, C., Nascimento, T., Marinho, C.A., Sarmento, C., De-Oliveira, I.R., Cunha, M., et al. (1995). SDZ 216-525, a selective 5-HT1A receptor antagonist, reverts zinc-induced inhibition of water intake in dehydrated rats. Braz. J. Med. Biol. Res. 28, 711-714.
42. Freo, U., Merico, A., Ermani, M., and Ori, C. (2010). Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N -propylamino) tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine. Brain Res. 1335, 24-34.
43. Fujita, S., Kiguchi, M., Lee, J., Terakado, M., Suga, K., Hatanaka, H., and Koshikawa, N. (2008). 5-HT(1A) and 5-HT(1B) receptors in the ventrolateral striatum differentially modulate apomorphineinduced jaw movements in rats. J. Oral Sci. 50, 387-395.
44. Fuller, R.W. (1991). Role of serotonin in therapy of depression and related disorders. J. Clin. Psychiatry 52 (Suppl.), 52-57.
45. Garver, D.L. (1974). Disease of the nervous system: psychiatric disorders. In: Clinical chemistry: theory analysis and correlations. L.A. Kaplan and A.J. Pesce, eds. (St. Louis: C.V. Mosby), pp. 864-881.
46. Gillin, J.C., Sohn, J.W., Stahl, S.M., Lardon, M., Kelsoe, J., Rapaport, M., Ruiz, C., and Golshan, S. (1996). Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology 15, 109-115. (Pubitemid 26255157)
47. Grace, K.P., Liu, H., and Horner, R.L. (2012). 5-HT1A receptorresponsive pedunculopontine tegmental neurons suppress REM sleep and respiratory motor activity. J. Neurosci. 32, 1622-1633.
48. Griebel, G., Rodgers, R.J., Perrault, G., and Sanger, D.J. (1999). Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists. Psychopharmacology (Berl.) 144, 121-130. (Pubitemid 29264427)
49. Griebel, G., Rodgers, R.J., Perrault, G., and Sanger, D.J. (2000). The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39, 1848-1857. (Pubitemid 30398488)
50. Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., and Hen, R. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396-400. (Pubitemid 34272867)
51. Gunther, L., Rothe, J., Rex, A., Voigt, J.P., Millan, M.J., Fink, H., and Bert, B. (2011). 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test. Neuropharmacology 61, 433-441.
52. Guptarak, J., Sarkar, J., Hiegel, C., and Uphouse, L. (2010). Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition. Horm. Behav. 58, 290-296.
53. Hall, H., Lundkvist, C., Halldin, C., Farde, L., Pike, V.W., McCarron, J.A., Fletcher, A., Cliffe, I.A., Barf, T., Wikstrom, H., et al. (1997). Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [ 3 H]WAY-100635 and [ 11 C] way-100635. Brain Res. 745, 96-108. (Pubitemid 27055749)
54. Heisler, L.K., Chu, H.M., Brennan, T.J., Danao, J.A., Bajwa, P., Parsons, L.H., and Tecott, L.H. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U.S.A. 95, 15049-15054. (Pubitemid 29003754)
55. Hicks, P.B. (1990). The effect of serotonergic agents on haloperidolinduced catalepsy. Life Sci. 47, 1609-1615.
56. Humphrey, P.P., Hartig, P., and Hoyer, D. (1993). A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14, 233-236. (Pubitemid 23172506)
57. Hurley, P.T., McMahon, R.A., Fanning, P., O'Boyle, K.M., Rogers, M., and Martin, F. (1998). Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells. Br. J. Pharmacol. 124, 1238-1244. (Pubitemid 28333948)
58. Ichikawa, J. and Meltzer, H.Y. (1999). Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur. J. Pharmacol. 380, R1-3. (Pubitemid 29467326)
59. Idova, G.V. and Davydova, S.M. (2010). Involvement of presynaptic 5-HT(1A) receptors in immunomodulation in conditions of psychoemotional tension. Neurosci. Behav. Physiol. 40, 495-499.
60. Kelai, S., Renoir, T., Chouchana, L., Saurini, F., Hanoun, N., Hamon, M., and Lanfumey, L. (2008). Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6J mice. J. Neurochem. 107, 1660-1670.
61. Kennett, G.A., Marcou, M., Dourish, C.T., and Curzon, G. (1987). Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138, 53-60. (Pubitemid 17093074)
62. Kishimoto, K., Koyama, S., and Akaike, N. (2001). Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacology 41, 529-538. (Pubitemid 32924962)
63. Knapp, D.J., Overstreet, D.H., and Crews, F.T. (1998). Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Brain Res. 782, 1-10. (Pubitemid 28122974)
64. Kobilka, B.K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T.S., Francke, U., Lefkowitz, R.J., and Caron, M.G. (1987). An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329, 75-79. (Pubitemid 17125898)
65. Kondaurova, E.M., Naumenko, V.S., and Popova, N.K. (2012). Effect of chronic activation of 5-HT 3 receptors on 5-HT 3, 5-HT 1A and 5-HT 2A receptors functional activity and expression of key genes of the brain serotonin system Neurosci. Lett. 522, 52-56.
66. Koyama, S., Kubo, C., Rhee, J.S., and Akaike, N. (1999). Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. J. Physiol. 518 (Pt 2), 525-538. (Pubitemid 29366747)
67. Kulikov, A.V., Kolpakov, V.G., Maslova, G.B., Kozintsev, I., and Popova, N.K. (1994). Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats. Psychopharmacology (Berl.) 114, 172-174. (Pubitemid 24150536)
68. Kuroki, T., Ichikawa, J., Dai, J., and Meltzer, H.Y. (1996). R (+) -8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex. Brain Res. 743, 357-361. (Pubitemid 27028795)
69. Lai, M.K., Tsang, S.W., Francis, P.T., Esiri, M.M., Keene, J., Hope, T., and Chen, C.P. (2003). Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 974, 82-87. (Pubitemid 36549222)
70. Larsson, L.G., Stenfors, C., and Ross, S.B. (1998). Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists. Eur. J. Pharmacol. 346, 209-215. (Pubitemid 28234321)
71. Le Francois, B., Czesak, M., Steubl, D., and Albert, P.R. (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55, 977-985.
72. Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P.D., Bown, C.D., Sequeira, A., Kushwaha, N., Morris, S.J., Basak, A., et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23, 8788-8799. (Pubitemid 37176660)
73. Lemonde, S., Du, L., Bakish, D., Hrdina, P., and Albert, P.R. (2004). Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int. J. Neuropsychopharmacol. 7, 501-506. (Pubitemid 39648081)
74. Levine, E.S. and Jacobs, B.L. (1992). Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J. Neurosci. 12, 4037-4044.
75. Llado-Pelfort, L., Santana, N., Ghisi, V., Artigas, F., and Celada, P. (2012). 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb Cortex. 22, 1487-1497.
76. Lowther, S., De Paermentier, F., Cheetham, S.C., Crompton, M.R., Katona, C.L., and Horton, R.W. (1997). 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect. Disord. 42, 199-207. (Pubitemid 27170165)
77. Lucki, I., Singh, A., and Kreiss, D.S. (1994). Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18, 85-95. (Pubitemid 24058927)
78. Maes, M. and Meltzer, H.Y. (1995). The serotonin hypothesis of major depression. In: Psychopharmacology: The fourth generation of progress. E.E. Bloom and N.N. Kupfer, eds. (New York: Raven Press), pp. 933-944.
79. Mancilla-Diaz, J.M., Escartin-Perez, R.E., Lopez-Alonso, V.E., Floran-Garduno, B., and Romano-Camacho, J.B. (2005). Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior. Med. Sci. Monit. 11, BR74-79. (Pubitemid 40445975)
80. Matsuyama, S., Nei, K., and Tanaka, C. (1997). Regulation of GABA release via NMDA and 5-HT1A receptors in guinea pig dentate gyrus. Brain Res. 761, 105-112. (Pubitemid 27314739)
81. Meller, E., Goldstein, M., and Bohmaker, K. (1990). Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol. Pharmacol. 37, 231-237. (Pubitemid 20082987)
82. Meltzer, H.Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21, 106S-115S. (Pubitemid 29396478)
83. Meltzer, H.Y. and Sumiyoshi, T. (2008). Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav. Brain Res. 195, 98-102.
84. Miczek, K.A., Hussain, S., and Faccidomo, S. (1998). Alcoholheightened aggression in mice: attenuation by 5-HT1A receptor agonists. Psychopharmacology (Berl.) 139, 160-168. (Pubitemid 28416894)
85. Millan, M.J., Hjorth, S., Samanin, R., Schreiber, R., Jaffard, R., De Ladonchamps, B., Veiga, S., Goument, B., Peglion, J.L., Spedding, M., et al. (1997). S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J. Pharmacol. Exp. Ther. 282, 148-161. (Pubitemid 27425537)
86. Morita, M. and Nakayama, K. (2011). Mirtazapine in combination with perospirone synergistically enhances dopamine release in the rat prefrontal cortex via 5-HT1A receptor activation. Psych. Clin. Neurosci. 65, 246-253.
87. Morrison, K.E., Swallows, C.L., and Cooper, M.A. (2011). Effects of dominance status on conditioned defeat and expression of 5-HT1A and 5-HT2A receptors. Physiol. Behav. 104, 283-290.
88. Muller, C.P. and Huston, J.P. (2006). Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol. Sci. 27, 105-112. (Pubitemid 43184032)
89. Naumenko, V.S., Tkachev, S.E., Kulikov, A.V., Semenova, T.P., Amerhanov, Z.G., Smirnova, N.P., and Popova, N.K. (2008). The brain 5-HT1A receptor gene expression in hibernation. Genes Brain Behav. 7, 300-305. (Pubitemid 351490235)
90. Naumenko, V.S., Kondaurova, E.M., and Popova, N.K. (2009). Central 5-HT3 receptor-induced hypothermia in mice: interstrain differences and comparison with hypothermia mediated via 5-HT1A receptor. Neurosci. Lett. 465, 50-54.
91. Naumenko, V.S., Bazovkina, D.V., Kondaurova, E.M., Zubkov, E.A., and Kulikov, A.V. (2010). The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy. Genes Brain. Behav. 9, 519-524.
92. Naumenko, V.S., Kondaurova, E.M., and Popova, N.K. (2011). On the role of brain 5-HT7 receptor in the mechanism of hypothermia: comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor. Neuropharmacology 61, 1360-1365.
93. Naumenko, V.S., Kondaurova, E.M., Bazovkina, D.V., Tsybko, A.S., Tikhonova, M.A., Kulikov, A.V., and Popova, N.K. (2012a). Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 214, 59-67.
94. Naumenko, V.S., Tsybko, A.S., Bazovkina, D.V., and Popova, N.K. (2012b). Implication of 5-HT 2A receptors in the genetic mechanisms of the brain 5-HT system autoregulation. Mol. Biol. (Mosk.) 46, 375-380.
95. Nayebi, A.M., Rad, S.R., Saberian, M., Azimzadeh, S., and Samini, M. (2010). Buspirone improves 6-hydroxydopamineinduced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats. Pharmacol. Rep. 62, 258-264.
96. Newman-Tancredi, A. (2010). The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives. Curr. Opin. Investig. Drugs 11, 802-812.
97. Nutt, D.J. and Glue, P. (1991). Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. In: Psychopharmacology of anxiolytics and antidepressants. S.E. File, ed. (New York: Pergamon Press).
98. O'Connell, M.T. and Curzon, G. (1996). A comparison of the effects of 8-OH-DPAT pretreatment of different behavioural responses to 8-OH-DPAT. Eur. J. Pharmacol. 312, 137-143. (Pubitemid 26325671)
99. Oakey, R.J., Caron, M.G., Lefkowitz, R.J., and Seldin, M.F. (1991). Genomic organization of adrenergic and serotonin receptors in the mouse: linkage mapping of sequence-related genes provides a method for examining mammalian chromosome evolution. Genomics 10, 338-344.
100. Olivier, B., Mos, J., van Oorschot, R., and Hen, R. (1995). Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28 (Suppl. 2), 80-90.
101. Ou, X.M., Jafar-Nejad, H., Storring, J.M., Meng, J.H., Lemonde, S., and Albert, P.R. (2000). Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J. Biol. Chem. 275, 8161-8168. (Pubitemid 30159731)
102. Ou, X.M., Storring, J.M., Kushwaha, N., and Albert, P.R. (2001). Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J. Biol. Chem. 276, 14299-14307.
103. Overstreet, D.H., Commissaris, R.C., De La Garza, R. 2nd, File, S.E., Knapp, D.J., and Seiden, L.S. (2003). Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6, 101-110. (Pubitemid 36681960)
104. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T., and Toth, M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U.S.A. 95, 10734-10739.
105. Parsey, R.V., Oquendo, M.A., Simpson, N.R., Ogden, R.T., Van Heertum, R., Arango, V., and Mann, J.J. (2002). Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11] WAY-100635. Brain Res. 954, 173-182. (Pubitemid 35284657)
106. Peroutka, S.J. and Howell, T.A. (1994). The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 33, 319-324. (Pubitemid 24168701)
107. Pineyro, G. and Blier, P. (1999). Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51, 533-591. (Pubitemid 29420214)
108. Plaznik, A., Kostowski, W., and Stefanski, R. (1994). Limbic mechanisms of anxiolytics acting on 5-HT receptors. Pol. J. Pharmacol. 46, 473-477. (Pubitemid 24349166)
109. Pompeiano, M., Palacios, J.M., and Mengod, G. (1992). Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12, 440-453.
110. Popova, N.K. and Amstislavskaya, T.G. (2002). Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice. Psychoneuroendocrinology 27, 609-618. (Pubitemid 34310622)
111. Popova, N.K. and Ivanova, E.A. (2002). 5-HT(1A) receptor antagonist p-MPPI attenuates acute ethanol effects in mice and rats. Neurosci. Lett. 322, 1-4. (Pubitemid 34215016)
112. Popova, N.K. and Kulikov, A.V. (2010). Targeting tryptophan hydroxylase 2 in affective disorder. Expert Opin. Ther. Targets 14, 1259-1271.
113. Popova, N.K., Naumenko, V.S., Plyusnina, I.Z., and Kulikov, A.V. (2005). Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. J. Neurosci. Res. 80, 286-292. (Pubitemid 40676312)
114. Popova, N.K., Naumenko, V.S., Cybko, A.S., and Bazovkina, D.V. (2010). Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n -propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior. Neuroscience 169, 229-235.
115. Pruus, K., Skrebuhhova-Malmros, T., Rudissaar, R., Matto, V., and Allikmets, L. (2000). 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats. J. Physiol. Pharmacol. 51, 833-846.
116. Rainer, Q., Nguyen, H.T., Quesseveur, G., Gardier, A.M., David, D.J., and Guiard, B.P. (2012). Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Mol. Pharmacol. 81, 106-112.
117. Ramboz, S., Oosting, R., Amara, D.A., Kung, H.F., Blier, P., Mendelsohn, M., Mann, J.J., Brunner, D., and Hen, R. (1998). Serotonin receptor 1A knockout: an animal model of anxietyrelated disorder. Proc. Natl. Acad. Sci. U.S.A. 95, 14476-14481. (Pubitemid 28549392)
118. Rasmuson, S., Olsson, T., Henriksson, B.G., Kelly, P.A., Holmes, M.C., Seckl, J.R., and Mohammed, A.H. (1998). Environmental enrichment selectively increases 5-HT1A receptor mRNA expression and binding in the rat hippocampus. Brain Res. Mol. Brain Res. 53, 285-290. (Pubitemid 28085464)
119. Rawls, S.M., Shah, H., Ayoub, G., and Raffa, R.B. (2010). 5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians. Neurosci. Lett. 484, 113-117.
120. Raymond, J.R. (1991). Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor. J. Biol. Chem. 266, 14747-14753. (Pubitemid 21907567)
121. Riad, M., Watkins, K.C., Doucet, E., Hamon, M., and Descarries, L. (2001). Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci. 21, 8378-8386. (Pubitemid 33051436)
122. Riad, M., Rbah, L., Verdurand, M., Aznavour, N., Zimmer, L., and Descarries, L. (2008). Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 151, 692-700.
123. Richardson-Jones, J.W., Craige, C.P., Guiard, B.P., Stephen, A., Metzger, K.L., Kung, H.F., Gardier, A.M., Dranovsky, A., David, D.J., Beck, S.G., et al. (2010). 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40-52.
124. Robinson, D.S., Alms, D.R., Shrotriya, R.C., Messina, M., and Wickramaratne, P. (1989). Serotonergic anxiolytics and treatment of depression. Psychopathology 22 (Suppl. 1), 27-36. (Pubitemid 19104667)
125. Roman, V., Hagewoud, R., Luiten, P.G., and Meerlo, P. (2006). Differential effects of chronic partial sleep deprivation and stress on serotonin-1A and muscarinic acetylcholine receptor sensitivity. J. Sleep Res. 15, 386-394.
126. Rothe, C., Gutknecht, L., Freitag, C., Tauber, R., Mossner, R., Franke, P., Fritze, J., Wagner, G., Peikert, G., Wenda, B., et al. (2004). Association of a functional 1019C -G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol. 7, 189-192. (Pubitemid 38823287)
127. Saifullah, A.S. and Tomioka, K. (2003). 5-HT(7)-like receptors mediate serotonergic modulation of photo-responsiveness of the medulla bilateral neurons in the cricket, Gryllus bimaculatus . Zool. Sci. 20, 303-309. (Pubitemid 36784795)
128. Sakaue, M., Somboonthum, P., Nishihara, B., Koyama, Y., Hashimoto, H., Baba, A., and Matsuda, T. (2000). Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br. J. Pharmacol. 129, 1028-1034. (Pubitemid 30142918)
129. Samad, N., Perveen, T., Haider, S., Haleem, M.A., and Haleem, D.J. (2006). Inhibition of restraint-induced neuroendocrine and serotonergic responses by buspirone in rats. Pharmacol. Rep. 58, 636-642. (Pubitemid 44741682)
130. Sanberg, P.R., Bunsey, M.D., Giordano, M., and Norman, A.B. (1988). The catalepsy test: its ups and downs. Behav. Neurosci. 102, 748-759.
131. Santana, N., Bortolozzi, A., Serrats, J., Mengod, G., and Artigas, F. (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 14, 1100-1109. (Pubitemid 39258165)
132. Saudou, F. and Hen, R. (1994). 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv. Pharmacol. 30, 327-380.
133. Sawiniec, J., Borkowski, K., Ginalska, G., and Lewandowska-Stanek, H. (2007). Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior. Przegl. Lek. 64, 208-211.
134. Seth, P., Gajendiran, M., and Ganguly, D.K. (1997). Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: an in vivo spinal reflex study. Neuroreport 8, 2489-2493. (Pubitemid 27308448)
135. Sharp, T., Boothman, L., Raley, J., and Queree, P. (2007). Important messages in the ' post': recent discoveries in 5-HT neurone feedback control. Trends Pharmacol. Sci. 28, 629-636. (Pubitemid 350166575)
136. Shively, C.A., Friedman, D.P., Gage, H.D., Bounds, M.C., Brown-Proctor, C., Blair, J.B., Henderson, J.A., Smith, M.A., and Buchheimer, N. (2006). Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. Arch. Gen. Psychiatry 63, 396-403.
137. Song, B., Chen, W., and Marvizon, J.C. (2007). Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors. Brain Res. 1158, 57-62. (Pubitemid 47078941)
138. Sprouse, J.S. and Aghajanian, G.K. (1987). Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1, 3-9. (Pubitemid 17114243)
139. Stockmeier, C.A., Shapiro, L.A., Dilley, G.E., Kolli, T.N., Friedman, L., and Rajkowska, G. (1998). Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18, 7394-7401. (Pubitemid 28425823)
140. Takano, H., Ito, H., Takahashi, H., Arakawa, R., Okumura, M., Kodaka, F., Otsuka, T., Kato, M., and Suhara, T. (2011). Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [ 11 C]dasb and [ 11 C] WAY100635 in young healthy men. Synapse 65, 624-633.
141. Tomiyama, M., Kimura, T., Maeda, T., Kannari, K., Matsunaga, M., and Baba, M. (2005). A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease. Neurosci. Res. 52, 185-194. (Pubitemid 40704601)
142. van den Buuse, M., Ruimschotel, E., Martin, S., Risbrough, V.B., and Halberstadt, A.L. (2011). Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. Neuropharmacology 61, 209-216.
143. Wadenberg, M.L. (1996). Serotonergic mechanisms in neurolepticinduced catalepsy in the rat. Neurosci. Biobehav. Rev. 20, 325-339.
144. Wadenberg, M.L., Cortizo, L., and Ahlenius, S. (1994). Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav. 47, 509-513.
145. Wissink, S., Meijer, O., Pearce, D., van Der Burg, B., and van Der Saag, P.T. (2000). Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275, 1321-1326. (Pubitemid 30051188)
146. Witaker-Azmitia, E.C. and Azmitia, P.M. (1995). Anatomy, cell biology, and plasticity of the serotonergic system: neuropsychopharmacological applications for the action of psychotropic drugs. In: Psychopharmacology. The fourth generation of progress. F.E. Bloom and D.J. Kipfer, eds. (New York: Raven Press), pp. 443-449.
147. Xiao, H., Hapiak, V.M., Smith, K.A., Lin, L., Hobson, R.J., Plenefisch, J., and Komuniecki, R. (2006). SER-1, a Caenorhabditis elegans 5-HT2-like receptor, and a multi-PDZ domain containing protein (MPZ-1) interact in vulval muscle to facilitate serotonin-stimulated egg-laying. Dev. Biol. 298, 379-391. (Pubitemid 44441182)
148. Yuen, E.Y., Jiang, Q., Chen, P., Gu, Z., Feng, J., and Yan, Z. (2005). Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J. Neurosci. 25, 5488-5501. (Pubitemid 40800641)
149. Zega, G., Pennati, R., Fanzago, A., and De Bernardi, F. (2007). Serotonin involvement in the metamorphosis of the hydroid Eudendrium racemosum . Int. J. Dev. Biol. 51, 307-313. (Pubitemid 46997590)
150. Zhang, H., Wang, W., Jiang, Z., Shang, J., and Zhang, L. (2010). Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-α-induced immobility in the mouse forced swimming test. Arzneimittelforschung 60, 109-115.
151. Zifa, E. and Fillion, G. (1992). 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44, 401-458.